JP2009137992A5 - - Google Patents

Download PDF

Info

Publication number
JP2009137992A5
JP2009137992A5 JP2009004309A JP2009004309A JP2009137992A5 JP 2009137992 A5 JP2009137992 A5 JP 2009137992A5 JP 2009004309 A JP2009004309 A JP 2009004309A JP 2009004309 A JP2009004309 A JP 2009004309A JP 2009137992 A5 JP2009137992 A5 JP 2009137992A5
Authority
JP
Japan
Prior art keywords
peptide
column
concentration
peptides
toxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009004309A
Other languages
English (en)
Japanese (ja)
Other versions
JP4484941B2 (ja
JP2009137992A (ja
Filing date
Publication date
Priority claimed from US09/820,053 external-priority patent/US6875744B2/en
Application filed filed Critical
Publication of JP2009137992A publication Critical patent/JP2009137992A/ja
Publication of JP2009137992A5 publication Critical patent/JP2009137992A5/ja
Application granted granted Critical
Publication of JP4484941B2 publication Critical patent/JP4484941B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2009004309A 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法 Expired - Lifetime JP4484941B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27950501P 2001-03-28 2001-03-28
US09/820,053 US6875744B2 (en) 2001-03-28 2001-03-28 Short bioactive peptides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002578411A Division JP4310107B2 (ja) 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法

Publications (3)

Publication Number Publication Date
JP2009137992A JP2009137992A (ja) 2009-06-25
JP2009137992A5 true JP2009137992A5 (https=) 2010-04-02
JP4484941B2 JP4484941B2 (ja) 2010-06-16

Family

ID=26959709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002578411A Expired - Lifetime JP4310107B2 (ja) 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法
JP2009004309A Expired - Lifetime JP4484941B2 (ja) 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002578411A Expired - Lifetime JP4310107B2 (ja) 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法

Country Status (8)

Country Link
US (1) US7381704B2 (https=)
EP (2) EP1379265A4 (https=)
JP (2) JP4310107B2 (https=)
KR (1) KR100891157B1 (https=)
AU (1) AU2002255952A1 (https=)
CA (1) CA2441562C (https=)
ES (1) ES2389285T3 (https=)
WO (1) WO2002079408A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8084424B2 (en) * 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
JP2005281225A (ja) * 2004-03-30 2005-10-13 Japan Science & Technology Agency 新規塩基性抗菌ペプチド及びその利用
US20090220435A1 (en) * 2005-07-27 2009-09-03 Nastech Pharmaceutical Company Inc. Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
US7601361B2 (en) * 2005-10-03 2009-10-13 E. I. Du Pont De Nemours And Company Process for providing antimicrobial surfaces
CA2822302A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CN105288581A (zh) * 2006-06-01 2016-02-03 治疗剂肽有限公司 聚合生物表面活性剂
SI2027152T1 (sl) 2006-06-13 2012-03-30 Helix Biomedix Inc Peptidni fragmenti za sprožitev sinteze proteinov ekstracelularnega matrixa
KR100742982B1 (ko) * 2006-06-22 2007-07-26 케이맥(주) 초점 타원계측기
EP2125878B1 (en) * 2007-01-05 2013-02-20 Helix Biomedix, Inc. Short bio-active peptides for cellular and immunological modulation
WO2008131508A1 (en) * 2007-05-01 2008-11-06 Fundação De Amparo À Pesquisa Do Estado De São Paulo - Fapesp Analgesic compounds
EP2205623B1 (en) 2007-10-29 2016-03-16 Helix Biomedix Inc. Protective skin care tetrapeptides
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
EP2168591A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
US20120270770A1 (en) * 2010-08-03 2012-10-25 Jesse Michael Jaynes Anti-angiogenic peptides and their uses
US9493562B2 (en) 2012-07-19 2016-11-15 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
ITBS20120126A1 (it) * 2012-08-01 2014-02-02 Paoli Ambrosi Gianfranco De Composizione antibatterica per uso topico
WO2014040605A1 (en) * 2013-04-09 2014-03-20 Elawdan Khaled Mohey Eldin New peptides as a monotherapy in malignancy control
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
WO2016061133A1 (en) 2014-10-14 2016-04-21 Riptide Bioscience, Inc. Peptides having anti-inflammatory properties
CN105061562B (zh) * 2015-09-16 2018-01-12 山东电力中心医院 一种具有抗肺癌作用的寡肽及其应用
US9439917B1 (en) * 2015-12-28 2016-09-13 Shetal Amit Shah Anti-blepharitis compositions and their use
JP7105696B2 (ja) 2016-02-29 2022-07-25 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド
JP7305614B2 (ja) * 2017-07-19 2023-07-10 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 抗生物質耐性細菌感染症の処置のための安定化抗菌ペプチド
CN112040968B (zh) * 2018-04-30 2024-01-30 欧莱雅 对人肌肉烟碱性乙酰胆碱受体具有高结合亲和力的生物活性肽
JP2022527133A (ja) 2019-04-12 2022-05-30 リップタイド バイオサイエンス インコーポレイテッド マクロファージの活性を調節する方法
FR3099060B1 (fr) * 2019-07-26 2022-01-14 Bionuclei Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique
TR2023016596A2 (tr) * 2023-12-06 2024-01-22 Karadeniz Teknik Ueniversitesi Teknoloji Transferi Uygulama Ve Arastirma Merkezi Mueduerluegue Anti̇bi̇yoti̇klere alternati̇f yeni̇ ki̇tosan konjuge anti̇mi̇krobi̇yal pepti̇ti̇n geli̇şti̇ri̇lmesi̇
WO2025157595A2 (en) * 2024-01-25 2025-07-31 Lipotrue, S.L. Peptides and cosmetic compositions for use in the treatment of acne and its related skin conditions
CN120209088B (zh) * 2025-03-07 2026-03-03 黄小柯 一种多效蛋白mel3及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355104A (en) 1980-06-17 1982-10-19 Kabigen Ab Bacteriolytic proteins
US4520016A (en) 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
KR970006154B1 (ko) 1987-07-06 1997-04-24 루이지아나 스테이트 유니버시티 아그리컬춰럴 앤드 메카니칼 컬리지 용해성 펩티드에 의한 진핵 병원체와 신생물의 억제 및 섬유아세포와 임파구의 자극
US5861478A (en) 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
CA1327311C (en) 1987-07-06 1994-03-01 Jesse M. Jaynes Therapeutic antimicrobial polypeptides, their use and methods for preparation
DE69034085T2 (de) * 1989-04-10 2004-05-27 Helix BioMedix, Inc., Bothell Lytsche und proliferative Peptide und deren Verwendung als Pharmaka und Phytopharmaka
CA2107674A1 (en) 1991-04-08 1992-10-09 W. Lee Maloy Novel peptide compositions and uses therefor
US5955573A (en) 1993-06-04 1999-09-21 Demegen, Inc. Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
AU7050294A (en) 1993-06-04 1995-01-03 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
AU1086595A (en) 1993-11-08 1995-05-29 Demeter Biotechnologies, Ltd. Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
IL114697A0 (en) 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
WO1997021728A1 (en) 1995-12-12 1997-06-19 Karolinska Innovations Ab PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
US6566334B1 (en) 1997-02-06 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Short amphipathic peptides with activity against bacteria and intracellular pathogens
US6635740B1 (en) 1997-03-27 2003-10-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Ligand/lytic peptide compositions and methods of use
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
AU2631501A (en) 2000-01-06 2001-07-16 Monsanto Technology Llc Preparation of deallergenized proteins and permuteins

Similar Documents

Publication Publication Date Title
JP2009137992A5 (https=)
SG158112A1 (en) Hepatocyte growth factor (hgf) binding proteins
UA106756C2 (uk) Генетичні маркери, асоційовані з відповіддю на інтерферон-альфа
MY153198A (en) Inhibitors of protein aggregation
DE602006012469D1 (de) Bipolare medizinische elektrodenanordnung mit kanüle und entfernbarer anschlusselektrode
UA95715C2 (ru) Фосфадиазиновые производные, фармацевтическая композиция и их применение
WO2007143098A3 (en) Hepatocyte growth factor (hgf) binding proteins
NZ707292A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
NZ603200A (en) Peptides and their use
SI2176252T1 (sl) 2,3-dihidrobenzo(1,4)dioksin-2-ilmetilni derivati kot alfa2C antagonisti za uporabo v zdravljenju bolezni perifernega in centralnega živčnega sistema
ATE525070T1 (de) Silbininkomponente zur behandlung von hepatitis
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
WO2008045564A3 (en) Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
MX2010001849A (es) Depsipeptidos ciclicos.
IL209879A0 (en) Substituted pteridines ,pharmaceutical compositions containing them and their use in the manufacture of medicaments for treating inflammatory diseases
NO20065536L (no) Behandling av astma hos barn
GEP20156332B (en) Pyrazoles as crth2 antagonists
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
PL2185561T3 (pl) Pochodne 1,2,3,4-tetrahydropirolo(1,2-a)pirazyno-6-karboksamidów i 2,3,4,5-tetrahydropirolo(1,2-a)-diazepino-7-karboksamidów, ich wytwarzanie i zastosowanie terapeutyczne
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
ITMI20050887A1 (it) Letto perfezionato elevabile e regolabile in modo da facilitare la salita e la discesa del paziente
ATE524488T1 (de) Lysobactinamide
RU2007122391A (ru) S-миртазапин для лечения приливов
WO2006133194A3 (en) Methods for treating viral infection with oral or injectible drug solution